HRMY
Harmony Biosciences Holdings, Inc. Common Stock
Nasdaq · usd
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) trades at $36.78 (+1.80%) as of 2:04:54 PM EDT on Oct 26, 2026, -11.06% over the past month. Market cap is $2.1B, with 5.0 days to cover in short interest.
Stock performance
How Harmony Biosciences Holdings, Inc. Common Stock (HRMY) stock has performed from one day to one year, with its 52-week range.
- 1D
- +1.56%
- 1W
- -2.25%
- 1M
- -11.06%
- YTD
- -1.94%
- 1Y
- +21.87%
- 52-wk range
- $25.90 – $43.49
Key statistics
Today's trading snapshot for HRMY: day range, open, previous close, volume and market cap.
- Day range
- $36.13 – $37.19
- Open
- $36.28
- Prev close
- $36.13
- Volume
- 282.87K
- Market cap
- $2.1B
- Shares out
- 58.24M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Harmony Biosciences Holdings, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- 11.61
- P/S
- 2.19
- P/B
- 2.11
- P/FCF
- 5.93
- ROE
- 18.1%
- ROA
- 13.2%
- Debt/Equity
- 0.15
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Harmony Biosciences Holdings, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Ceo appointmentOct 13, 2026
On October 12, 2026, the Company announced that Peter Anastasiou, the Company's current Chief Operating Officer, has been appointed by the Board to serve as President and Chief Executive Officer of the Company, effective as of January 1, 2027, at 12:00 a.m. Eastern Time.
- Investor presentationAug 4, 2026
On August 4, 2026, the Company posted an investor presentation to its website at ttps://ir.harmonybiosciences.com (the "Investor Presentation"). The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others.
- Preliminary resultsJul 16, 2026
On July 16, 2026, Harmony Biosciences Holdings, Inc. (the "Company") issued a press release announcing its preliminary net product revenue for the second quarter of 2026.
- Annual meeting resultsMay 14, 2026
On May 14, 2026, Harmony Biosciences Holdings, Inc. held its 2026 Annual Meeting of Stockholders. At the Annual Meeting, stockholders voted on the following three proposals... Based on the votes set forth above, each of the director nominees was duly elected.
- Investor presentationMay 7, 2026
On May 7, 2026, the Company posted an investor presentation to its website at ttps://ir.harmonybiosciences.com (the "Investor Presentation"). The Company expects to use the Investor Presentation, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others.
HRMY short interest
How heavily HRMY is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 5.0
- Short interest
- 5.53M
- Avg volume
- 1.11M
As of · reported to FINRA twice monthly.
HRMY news
The latest news and headlines about Harmony Biosciences Holdings, Inc. Common Stock (HRMY).
- HRMY or ARGX: Which Is the Better Value Stock Right Now?positiveZacks Investment Research· Oct 22, 2026
- HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?positiveZacks Investment Research· Oct 16, 2026
- Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsightpositiveGlobeNewswire Inc.· Oct 13, 2026
- Why Harmony Biosciences Stock Got Mashed on MondaynegativeThe Motley Fool· Oct 12, 2026
- Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of GrowthpositiveGlobeNewswire Inc.· Oct 12, 2026
Frequently asked questions
What is the Harmony Biosciences Holdings, Inc. Common Stock (HRMY) stock price today?
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) is trading at $36.78 (+1.80% on the day) as of 2:04:54 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Harmony Biosciences Holdings, Inc. Common Stock?
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases.
What is the short interest in HRMY?
As of Sep 30, 2026, HRMY has 5.53M shares short and 5.0 days to cover.
What exchange is HRMY listed on?
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of HRMY with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a HRMY analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.